Article Information
History
- January 17, 2024.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Ariana Hernandez-Cordero, MSc1,
- Laurent Thomas, PhD2,3,4,5,
- Alice Smail, MSc1,
- Zhao Qin Lim, MSc1,6,
- Jake R Saklatvala, PhD1,
- Raymond Chung, MSc7,
- Charles J Curtis, MRes7,
- Patrick Baum, PhD8,
- Sudha Visvanathan, PhD9,
- A David Burden, MD10,
- Hywel L Cooper, BM11,
- Giles Dunnill, MD12,
- Christopher EM Griffiths, MD13,14,
- Nick J Levell, MD15,
- Richard Parslew, MD16,
- Nick J Reynolds, M.D.17,
- Shyamal Wahie, MD18,
- Richard B Warren, PhD13,19,
- Andrew Wright, MB ChB20,
- The APRICOT and PLUM Study Team,
- Michael Simpson, PhD1,
- Kristian Hveem, MD PhD3,21,
- Jonathan N Barker, MD22,
- Nick Dand, PhD1,
- Mari Loset, PhD3,23,
- Catherine H Smith, MD22 and
- Francesca Capon, PhD.1,*
- 1Department of Medical and Molecular Genetics, School of Basic and Medical Biosciences, King’s College London, London, UK
- 2Department of Clinical and Molecular Medicine, NTNU-Norwegian University of Science and Technology, Trondheim, Norway
- 3HUNT Center for Molecular and Clinical Epidemiology, Department of Public Health and Nursing, NTNU-Norwegian University of Science and Technology, Trondheim, Norway
- 4BioCore-Bioinformatics Core Facility, NTNU-Norwegian University of Science and Technology, Trondheim, Norway
- 5Clinic of Laboratory Medicine, St. Olavs Hospital, Trondheim University Hospital, Trondheim, Norway
- 6Department of Pathology and Laboratory Medicine, KK Women’s and Children’s Hospital, Singapore, Singapore
- 7NIHR BioResource Centre Maudsley, NIHR Maudsley Biomedical Research Centre (BRC) at South London and Maudsley NHS Foundation Trust (SLaM) & Institute of Psychiatry, Psychology and Neuroscience (IoPPN), King’s College London, London, UK
- 8Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany
- 9Boehringer Ingelheim Pharmaceuticals, Ridgefield, USA
- 10School of Infection and Immunity, University of Glasgow, Glasgow, UK
- 11Portsmouth Dermatology Unit, Portsmouth Hospitals Trust, Portsmouth, UK
- 12Bristol Royal Infirmary, Bristol, UK
- 13NIHR Manchester Biomedical Research Centre, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK
- 14Department of Dermatology, King’s College Hospital, King’s College London, London, UK
- 15Norwich Medical School, University of East Anglia, Norwich, UK
- 16Department of Dermatology, Royal Liverpool Hospitals, Liverpool, UK
- 17Institute of Cellular Medicine, Medical School, Newcastle University, Newcastle NIHR Biomedical Research Centre and the Department of Dermatology, Royal Victoria Infirmary, Newcastle Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK
- 18University Hospital of North Durham, Durham; Darlington Memorial Hospital, Darlington, UK
- 19Dermatology Centre, Northern Care Alliance NHS Foundation Trust, Manchester, UK
- 20St Lukes Hospital, Bradford, UK; Centre for Skin Science, University of Bradford, Bradford, UK
- 21Department of Innovation and Research, St. Olavs Hospital, Trondheim University Hospital, Trondheim, Norway
- 22St John’s Institute of Dermatology, School of Basic and Medical Biosciences, King’s College London, London, UK
- 23Department of Dermatology, Clinic of Orthopedy, Rheumatology and Dermatology, St. Olavs Hospital, Trondheim University Hospital, Trondheim, Norway
- ↵*Correspondence to: Francesca Capon, 9th floor Tower Wing, Guy’s Hospital, London SE1 9RT, UK; francesca.capon{at}kcl.ac.uk.
Posted January 17, 2024.
A genome-wide meta-analysis of palmoplantar pustulosis implicates Th2 responses and cigarette smoking in disease pathogenesis
